The device consists of a small sensor, about the size of a quarter, that’s worn on the back of the upper arm to continuously track glucose levels.
Patients can place a hand-held reader near the device to see their current glucose levels, trends, patterns and where those levels might be headed.
But she said in an email the price will be “very similar” to the price in Europe, where the reader costs about $69, and each sensor, which lasts about 14 days, also costs about $69, before insurance.
In the U.S., the sensor will last about 10 days.
Rasa Kazlauskaite, director of the diabetes technology Initiative at Rush University Medical Center, said the new device could be an exciting development for patients, but she cautioned that, ultimately, its usefulness will depend on its accuracy.